Novel melanoma antigen peptide and uses thereof

Details for Australian Patent Application No. 2009289277 (hide)

Owner INSERM (Institut National de la Sante et de la Recherche Medicale)

Inventors Labarriere, Nathalie; Moreau-Aubry, Agnes; Godet, Yann

Agent Wrays

Pub. Number AU-A-2009289277

PCT Pub. Number WO2010/026165

Priority 08305517.8 02.09.08 EP

Filing date 2 September 2009

Wipo publication date 11 March 2010

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/026165 Priority application(s): WO2010/026165

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289280-Fc gamma receptor for the treatment of B cell mediated multiple sclerosis

2009289275-Label, especially for a reusable container